The BalancedInvestor Club

BIAFW Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)—0.0% YoY
Profit margin-242.0%
Market cap—

Valuation

Forward P/E
—
PEG ratio
—
P/B
—
P/S (TTM)
—
EV/EBITDA
—

Profitability & growth

ROE (TTM)
-301.8%
Operating margin
-197.0%
Revenue growth YoY
-27.8%
Dividend yield
—
Beta
-0.81

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About bioAffinity Technologies Inc. Warrant

bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
3300 NACOGDOCHES ROAD, SAN ANTONIO, TX
Fiscal year end
December
Latest quarter
Dec 31, 2025
Shares outstanding$0
52W high$0.81
52W low$0.05

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer